Back to ENTA

Krensavage Asset Management, LLC → ENTA

Krensavage Asset Management, LLC ENTA Position History

Enanta Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$37.8M
Q3 2026
Peak value
$43.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$43.6M
Q1 2026$36.2M
Q2 2026$41.8M
Q3 2026$37.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$37.8M2.87M——
Q2 2026$41.8M2.87M——
Q1 2026$36.2M2.87M——
Q4 2025$43.6M2.77M——

Other funds holding ENTA

Other Krensavage Asset Management, LLC positions

UTHR

UNITED THERAPEUTICS CORP

$50M
UTHR

UNITED THERAPEUTICS CORP

$44.5M
JAZZ

JAZZ PHARMACEUTICALS PLC

$40.4M
JAZZ

JAZZ PHARMACEUTICALS PLC

$38.9M
UTHR

UNITED THERAPEUTICS CORP

$37.5M
UTHR

UNITED THERAPEUTICS CORP

$35.9M
JAZZ

JAZZ PHARMACEUTICALS PLC

$31.7M
BMRN

BIOMARIN PHARMACEUTICAL INC

$31.5M